Toso: A New Drug Target for MS?

Toso is a transmembrane protein that normally modulates innate immunity. Dampening its effects quells autoimmunity in a mouse model of multiple sclerosis.

A protein named after a Japanese drink—Toso—may provide a new drug target for...

Drug Development

Editors' Pick

Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden.

Westerlind H, Ramanujam R, Uvehag D, Kuja-Halkola R, Boman M, Bottai M, Lichtenstein P, Hillert J

Brain. 2014 Jan 17. PMID: 24441172. Abstract

MS Research Roundup: January 17, 2014

MS Rising in Global Disease Rankings; Booming Business in MS Drugs; Life's Big Questions

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, Drug Development, People

Papers: 10 Jan 2014 - 17 Jan 2014

Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation.

Editors' Pick

Sources of information and behavioral patterns in online health forums: qualitative study.

Sudau F, Friede T, Grabowski J, Koschack J, Makedonski P, Himmel W

J Med Internet Res. 2014; 16(1):e10. Epub 1969 Dec 31. PMID: 24425598. Abstract

MS Patient, Ph.D.: That’s Not PPMS? Well, It’s My PPMS

Consider individual differences in disease manifestation before dismissing a symptom as unrelated to MS

I’ve seen many neurologists. And my experiences with these different neurologists have been, shall we say...

People

MS Research Roundup: January 15, 2014

Surprising Alcohol Finding; Bigger, Better Patient Research Databases; Start-Up Lessons; MS and Obamacare

Items of interest to multiple sclerosis researchers from around the Web

Clinical Research, Laboratory Research, Methods, People

Cognitive Test Analysis May Determine Reliable MS Change Over Time

A new strategy helps determine whether change over time on commonly used neuropsychological tests reflects reliable improvement or decline in individuals with MS

A new analytic strategy may help determine whether change over time on commonly used neuropsychological tests reflects...

Clinical Research

Cannabinoid Receptor Variant Linked to MS Neurodegeneration

Type-1 cannabinoid receptors may be a useful molecular target for preventing neuronal loss and cognitive problems in multiple sclerosis

Type-1 cannabinoid receptors could be a useful molecular target for preventing neuronal loss and cognitive problems in...

Clinical Research

UCSF Neuroimmunology Seminar

17 Jan 2014

UCSF Mission Bay, Rock Hall 102

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

Toso: A New Drug Target for MS?

MS Research Roundup: January 17, 2014

Papers: 10 Jan 2014 - 17 Jan 2014

MS Patient, Ph.D.: That’s Not PPMS? Well, It’s My PPMS

MS Research Roundup: January 15, 2014

Cognitive Test Analysis May Determine Reliable MS Change Over Time

Cannabinoid Receptor Variant Linked to MS Neurodegeneration

UCSF Neuroimmunology Seminar

Pages

MSDF Footer

Search form

Papers: 10 Jan 2014 - 17 Jan 2014

Pages